I would just add in terms of infrastructure that I think it's a critical issue. Many times the infrastructure will only change when there is support from partnerships--partnerships with governments, partnerships with NGOs, partnerships with companies like Abbott, Glaxo, and others.
In the countries where you are starting to see significant changes in infrastructure capacity.... Take Malawi, for example, where the HIV rate six years ago was running 13% to 15%. Through a lot of collaboration partnerships, that HIV rate now is down to 12%. They've dropped several points. So in order for that type of thing to happen, I think these are the sorts of partnerships and collaborations that are needed.
In terms of getting access to the medication, six, seven, eight years ago, this was a huge issue, but today many of these countries have moved on. They're now getting source drugs from countries that they weren't six years ago.
I think that's another reason why you're not seeing people asking from Africa. I'm not sure how many people here today are here representing the African community, but I think you have to ask yourselves, “Why are they not here? Why are they not asking for these medications?”